CannaMD

AUGUST 8, 2020

Researchers believe cannabis contains over 100 unique chemical compounds! THC is responsible for marijuana’s psychoactive effects. But CBD’s real calling card is that it’s popularly isolated from marijuana’s sibling plant, hemp , and can be legally sold (in most states) under much more relaxed regulations.

CBD 99

CBD DEA Research and Development Hemp 99

Medicinal Genomics

JULY 13, 2023

So here are just a dozen new developments, breakthroughs, and aha moments from this year’s summit that might just convince you to circle CannMed 24 on your calendar right now. the VP of Research & Development at Biopharmaceutical Research Company, Inc., But if you weren’t able to be there, you wouldn’t know that.

Research and Development 52

Research and Development Cannabinoids Medicine DEA 52

United Patients Group

APRIL 3, 2023

CVS, Walgreens, etc) as medical marijuana. A recommendation from a physician is simply permission (‘recommendation’) for the patient to use cannabis, which can be obtained in any state where medical marijuana is legal. A cannabis recommendation is a recommendation from a physician to use medical marijuana.

DEA 52

DEA Patients Conditions Cannabis 52

SpeedWeed

AUGUST 11, 2021

According to Dr. Sue Sisley, President of the Scottsdale Research Institute and longtime cannabis researcher, this new study is sorely needed in the community. Veterans are demanding objective cannabis drug development research, and the state of Michigan is fulfilling our collective obligation to our beloved Veteran community.”.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Veriheal

JUNE 24, 2021

health official reportedly slammed “ongoing federal restrictions that are inhibiting research into marijuana”. The Senator stated that the NIH has been reporting on “potentially promising peer-reviewed clinical research” and asked for an update on how the NIH was planning to proceed and navigate issues. .

Research and Development 52

Research and Development Clinical Trials Treatment Access 52

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). Prior to this week, the U.S.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

The Joint Blog

JUNE 4, 2021

Schedule I drugs like heroin, Lysergic Acid Diethylamide (LSD), and ecstasy are strictly regulated by the Federal Government but Marijuana has be made an exception in some states. Marijuana is also classified as a Schedule I drug but it has been given the approval for medical and recreational at some state levels. Kill cancer cells.

Conditions 32

Conditions Chronic Pain Marijuana Research and Development 32

Cannabis Law Report

AUGUST 12, 2022

Marijuana Moment report on some of the panels being proposed for 2023…… Voting is now open for the public to decide which panels will make the stage at next year’s South By Southwest (SXSW) festival—and there are about 100 marijuana- and psychedelics-related proposals to pick from. Which Political Party Will Legalize Weed?

Research and Development 52

Research and Development Events Topical Policy 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Weedistry

MARCH 7, 2019

Mounting evidence shows cannabinoids in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Marijuana Fights Cancer and Helps Manage Side Effects, Researchers Find.

THC 40

THC CBD Clinical Trials Research and Development 40

The Cannigma

JULY 3, 2023

The clues we have from existing literature indicate that while it’s probably safe, there’s insufficient clinical research to confirm or dispel it. Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future.

Research and Development 46

Research and Development Environment THC Microdosing 46

Cannabis Law Report

JANUARY 30, 2019

For nearly fifty years, the University of Mississippi has had the sole contract with the National Institute on Drug Abuse (NIDA) to grow cannabis for research purposes. However, over two years have passed without any new schedule I marijuana manufacturer registrations. RESPONSE: Yes. R ESPONSE: Yes. What is the status of this request?

Research and Development 63

Research and Development DEA CBD Law 63

Canna Law Blog

APRIL 22, 2020

the current and future treatment of emerging cannabinoids beyond CBD such as CBG , CBN , and synthetic CBD. researchers and companies to do so. legalized hemp in 2018, leading to a hemp-derived cannabinoid marketplace that is rapidly eclipsing the legal adult-use marijuana market. Some understand some of the nuances of the U.S.,

Supply Chain 53

Supply Chain Research and Development Hemp DEA 53

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

SpeedWeed

MARCH 5, 2021

One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Rescheduling cannabis will not necessarily facilitate clinical research.

Business 52

Business Policy Clinical Trials Research and Development 52

Cannabis Law Report

SEPTEMBER 20, 2019

DEA increases the cannabis research quota. The Drug Enforcement Administration (DEA) announced annual quotas for the manufacture of controlled substances for research purposes, providing for 7,000 pounds of cannabis to be used in scientific studies. This represents a 30 percent increase from the 2019 cannabis quota.

Vaping 40

Vaping Banking Research and Development DEA 40

Cannabis Law Report

APRIL 14, 2022

Cannabis cultivation and processing are rapidly-growing industries, as hemp and both recreational and medical marijuana products are being legalized across the country. Although research is still underway, the effects of both short- and long-term exposure to pesticides by consuming (i.e., Danielle M. Hazeltine , Patrick J.

Environment 52

Environment Agriculture Compliance Compliance 52

Canna Law Blog

MAY 7, 2020

One of the main reasons why “marijuana” remains a federally illegal, Schedule I controlled substance is that, according to the Feds, it has no currently accepted medical use. Ole Miss got the cannabis study and research cultivation gig from the DEA (via a contract with the National Institute on Drug Abuse (NIDA)) in 1968.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

Canna Law Blog

NOVEMBER 6, 2021

Once off-limits because of federal prohibition, a trickle of research from the 1990s has grown into a stream. But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Research was permitted in the mid-20th century, until the law stepped in.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Marijuana Possession for Personal Use. Executive Summary. Relevant AAFP Policy. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Rick Doblin founded MAPS as an official 501(c)(3) non-profit research organization on April 8, 1986. Later that year, Doblin sued the DEA for the first time.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

SEPTEMBER 1, 2021

A visitor to any one of the 18 states that have “legalized” recreational cannabis (marijuana) use could be forgiven for concluding that such conduct in those states is in fact legal. 12] Ultimately, only Congress can amend the CSA itself to remove, or otherwise reform the treatment of cannabis under federal law. August 30, 2021.

Policy 100

Policy Cannabis Treatment Law 100

Veriheal

MAY 4, 2022

Well, according to a team of researchers from the United States and Switzerland, the cardiovascular outcome of using the plant is actually quite positive. The Coronary Artery Risk Development in Young Adults (CARDIA),” the study was published in the American Journal of Medicine. But just how true are these claims?

Research and Development 98

Research and Development Consumption Vaping Edibles 98

The Cannigma

SEPTEMBER 12, 2021

THC is the most prevalent, famous and researched cannabinoid by far. THC is the molecule responsible for the famous high associated with marijuana, but it also has a long list of therapeutic effects. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock). Who discovered THC?

THC 98

THC Research and Development Cannabinoids CBD 98

The Cannigma

FEBRUARY 16, 2022

To hear more about Steven’s research, what he hopes it will lead to, his predictions for the future of cannabis, how he is helping those most harmed by the war on drugs, and how you can help too, tune in today! SP: Yeah, so I guess right now, with my research, I am actually looking to create a catalog of trichomes. SP: Say that again.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse. Some states that have passed recreational or medical marijuana legislation are still negotiating the details for implementing these programs. each year since 2019.

Recreational 52

Recreational Data Cannabis DEA 52

SpeedWeed

DECEMBER 28, 2018

As first reported by Leafly, Altria has “over the past five years quietly patented dozens of devices that could be used to consume marijuana, a review of public documents at the US Patent and Trademark Office shows.” And then in December, Altria (formerly Phillip Morris) made a $1.8 RELATED STORY.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

JULY 30, 2019

Considering our current armed service use restrictions and the lack of legal tax and employment considerations for marijuana use, like the nation, Florida is not quite “ there ” yet. . Most reliable medical cannabis research filters into the U.S. “People do not know what’s going on. Federal Register. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

JULY 14, 2021

As always we suggest starting with Marijuana Moment for some concise reporting and analysis. Here Are The Full Details Of The New Federal Marijuana Legalization Bill From Chuck Schumer And Senate Colleagues. Marijuana Times. — Ron Wyden (@RonWyden) July 14, 2021. What do all the commentators think. MJ Biz say.

Legislation 71

Legislation Banking History Access 71